donepezil transdermal Adlarity
Selected indexed studies
- A study of once-a-week donepezil transdermal system's bioequivalence to oral donepezil in healthy volunteers: a plain language summary. (Neurodegener Dis Manag, 2023) [PMID:37671720]
- A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers. (Alzheimer Dis Assoc Disord, 2023) [PMID:37695107]
_Worker-drafted node — pending editorial review._
Connections
donepezil transdermal Adlarity is a side effect of
Sources
- A study of once-a-week donepezil transdermal system's bioequivalence to oral donepezil in healthy volunteers: a plain language summary. (2023) pubmed
- A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers. (2023) pubmed